Positive SARAH result will give long needed confidence to SRX. It will build excitement leading into the FOXFIRE data at ASCO.
If SARAH phase 3 data shows OS benefit in HCC and we already know liver PFS is prolonged in mCRC, then just maybe OS will also be extended in mCRC. Sure they are different clinical scenarios, but I expect a strong lead up into ASCO if SARAH is positive. Get in under $20 now, coz you won't be able to in a couple of months time.
- Forums
- ASX - By Stock
- SRX
- Ann: SARAH Awarded Oral Abstract at Upcoming EASL/ILC Meeting
Ann: SARAH Awarded Oral Abstract at Upcoming EASL/ILC Meeting, page-29
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SRX (ASX) to my watchlist
|
|||||
Last
15.5¢ |
Change
-0.005(3.13%) |
Mkt cap ! $65.79M |
Open | High | Low | Value | Volume |
16.0¢ | 16.0¢ | 15.3¢ | $395.4K | 2.535M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 2728183 | 15.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
15.5¢ | 84474 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 2728183 | 0.150 |
3 | 591379 | 0.145 |
1 | 60000 | 0.140 |
2 | 153847 | 0.130 |
3 | 266102 | 0.125 |
Price($) | Vol. | No. |
---|---|---|
0.155 | 84474 | 2 |
0.160 | 1659305 | 13 |
0.165 | 189786 | 8 |
0.170 | 99369 | 3 |
0.175 | 165000 | 1 |
Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
Featured News
SRX (ASX) Chart |